Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS | UNKNOWN |
| Copenhagen Trial Unit, Center for Clinical Intervention Research | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cognitive deficits are known to be a core feature of schizophrenia and seem to become manifest in the prodromal or Ultra-High Risk (UHR) state of psychosis. The cognitive deficits are known to pose a critical barrier to functional recovery. Hence it is of vital importance to find intervention strategies that can alleviate these cognitive deficits and consequently improve daily functioning, and quality of life, as well as the prognosis for UHR-patients. The investigators will examine whether:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard treatment + cognitive remediation | Experimental | The cognitive remediation therapy targets neurocognition as well as social cognition. |
|
| Standard treatment | Active Comparator | Patients allocated to the control condition are free to choose whatever standard treatment they are offered by the clinicians managing their treatment. Usually standard treatment consists of regular contact to health professionals in the in- and outpatient facilities in Copenhagen, Denmark, and encompass different kinds of supportive counselling |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cognitive remediation | Behavioral | Neurocognition will be trained using the NEAR model (Medalia et al. 2003), whereas the training of social cognitive skills will be by use of the SCIT manual (Social Cognition and Interaction Training) developed by Roberts et al. 2014. The intervention consists of 24 group sessions taking place once a week (two hours) and additional neurocognitive training at home. Furthermore, there will be a total of 12 individual sessions aiming at bridging the cognitive training to the everyday functioning of the patients. |
| Measure | Description | Time Frame |
|---|---|---|
| Brief Assessment of Cognition in Schizophrenia (BACS) | BACS will be used to assess changes in cognition at the cessation of treatment at (6 months) and 12 months post baseline. | 6 and 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Personal and Social Performance Scale (PSP) | 6 and 12 months | |
| Brief Psychiatric Rating Scale Expanded Version (BPRS-E) | 6 and 12 months | |
| Scale for the Assessment of Negative Symptoms (SANS) |
| Measure | Description | Time Frame |
|---|---|---|
| Schizophrenia Prediction/Proneness Instrument - Adult Version (SPI-A) | 6 and 12 months | |
| Behaviour Rating Inventory of Executive Function -Adult Version (BRIEF-A) | 6 and 12 months | |
Inclusion Criteria:
Age 18-40 yrs.
Fulfill criteria for being at Ultra-High Risk of psychosis (defined by one or more of the following):
Provided informed consent.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Merete Nordentoft, Professor | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | Principal Investigator |
| Louise B Glenthøj, MsC | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mental Health Centre Copenhagen | Copenhagen | 2400 | Denmark |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33005161 | Derived | Kristensen TD, Ebdrup BH, Hjorthoj C, Mandl RCW, Raghava JM, Jepsen JRM, Fagerlund B, Glenthoj LB, Wenneberg C, Krakauer K, Pantelis C, Glenthoj BY, Nordentoft M. No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis-A Randomized Clinical Trial. Front Psychiatry. 2020 Aug 28;11:873. doi: 10.3389/fpsyt.2020.00873. eCollection 2020. | |
| 32873460 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Standard treatment | Behavioral | Patients allocated to the control condition are free to choose whatever standard treatment they are offered by the clinicians managing their treatment. Usually standard treatment consists of regular contact to health professionals in the in- and outpatient facilities in Copenhagen, Denmark, and encompass different kinds of supportive counselling. |
|
| 6 and 12 months |
| The Montgomery-Åsberg Depression Rating Scale (MADRS) | 6 and 12 months |
| Global Functioning: Social and Role Scales |
| 6 and 12 months |
| Quality Of Life Scale (QOLS). | 6 and 12 months |
| Comprehensive Assessment of At-Risk Mental States (CAARMS) | 6 and 12 months |
| The Awareness of Social Inference Test (TASIT) | 6 and 12 months |
| Emotion Recognition Task (ERT) | Emotion Recognition Task from CANTAB | 6 and 12 months |
| Social Responsiveness Scale (SRS) | 6 and 12 months |
| Social Cognition Screening Questionnaire (SCSQ) | 6 and 12 months |
| Adverse events | Number of participants with adverse events | 6 and 12 months |
| The High-Risk Social Challenge (HiSoC) Task | 6 and 12 months |
| Derived |
| Glenthoj LB, Mariegaard LS, Fagerlund B, Jepsen JRM, Kristensen TD, Wenneberg C, Krakauer K, Medalia A, Roberts DL, Hjorthoj C, Nordentoft M. Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial. Schizophr Res. 2020 Oct;224:151-158. doi: 10.1016/j.schres.2020.08.016. Epub 2020 Aug 29. |
| 32008981 | Derived | Wenneberg C, Nordentoft M, Rostrup E, Glenthoj LB, Bojesen KB, Fagerlund B, Hjorthoj C, Krakauer K, Kristensen TD, Schwartz C, Edden RAE, Broberg BV, Glenthoj BY. Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Jun;5(6):569-579. doi: 10.1016/j.bpsc.2019.12.005. Epub 2019 Dec 19. |
| 25623736 | Derived | Glenthoj LB, Fagerlund B, Randers L, Hjorthoj CR, Wenneberg C, Krakauer K, Vosgerau A, Gluud C, Medalia A, Roberts DL, Nordentoft M. The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial. Trials. 2015 Jan 27;16:25. doi: 10.1186/s13063-014-0542-8. |
| ID | Term |
|---|---|
| D000072466 | Cognitive Remediation |
| D015610 | Serum Bactericidal Test |
| ID | Term |
|---|---|
| D001521 | Behavior Therapy |
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |
| D008826 | Microbial Sensitivity Tests |
| D008828 | Microbiological Techniques |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D008919 | Investigative Techniques |
| D004353 | Drug Evaluation, Preclinical |
| D005069 | Evaluation Studies as Topic |
Not provided
Not provided